טוען...
CAR T and CAR NK cells in multiple myeloma: expanding the targets
Multiple myeloma (MM) is a haematologic malignancy with significant improvements in the overall survival over the last decade. However, patients still relapse and die due to a lack of treatment options. Ultimately, novel therapies with the potential for long term remissions are needed for patients w...
שמור ב:
| הוצא לאור ב: | Best Pract Res Clin Haematol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7137578/ https://ncbi.nlm.nih.gov/pubmed/32139020 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.beha.2020.101141 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|